House committee seeks testimony from 'Pharma Bro' Shkreli

WASHINGTON (Reuters) - A U.S. congressional panel has asked pharmaceutical entrepreneur Martin Shkreli to testify at a Jan. 26 hearing about his company's decision to raise the price of a life-saving prescription drug, according to a Republican committee staffer.